Published: 10 March 2021
Author(s): Petros Kalogeropoulos, Helen Bilianou, Vana Kolovou, Athanasios Manolis, Genovefa D. Kolovou
Issue: June 2021
Section: Letter to the Editor

Although fasting triglyceride (TG) levels are routinely measured in clinical practice, studies indicate that postprandial hypertriglyceridemia may be also related to atherosclerosis [1]. Currently, there are expert panel statements [2] and guidelines [3] stating that non-fasting TG levels are clinically valid and that postprandial TG (pTG) measurements may be useful to evaluate cardiovascular (CV) risk.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.